Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in... Prophylactic antiretroviral regimens for prevention of mother-to- child transmission of HIV in resource-limited settings Elise Arrive´ and Franc ¸ois Dabis INSERM 593, Institute for Public Health, Epidemiology Purpose of review and Development (ISPED), Victor Segalen University, With the large international mobilization against HIV/AIDS, more HIV-infected people in Bordeaux, France resource-limited settings have access to antiretroviral therapy, including pregnant Correspondence to Dr Elise Arrive´, Unite´ INSERM 593, women. The relevance of simplified prophylactic antiretroviral regimens for the Institut de Sante´ Publique, Epide´miologie et De´veloppement (ISPED), Universite´ Victor Segalen prevention of mother-to-child transmission of HIV may become questionable due to their Bordeaux 2, 146, rue Le´o Saignat, 33076 lower efficacy and their higher risk of inducing viral resistance than fully suppressive BORDEAUX Cedex, France Tel: +33 5 5757 4810; fax: +33 5 5757 4528; antiretroviral therapy. e-mail: Elise.arrive@isped.u-bordeaux2.fr Recent findings Field implementation of current recommendations, impact of prophylactic regimens on Current Opinion in HIV and AIDS 2008, 3:161– subsequent antiretroviral therapy response and possible new indications of antiretroviral therapy in pregnant women will be reviewed in this paper. Summary Prophylactic antiretroviral prevention of mother-to-child transmission regimens reached only 10% of the HIV-infected pregnant women in 2006, who were usually offered single- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings

Current Opinion in HIV and Aids , Volume 3 (2) – Mar 1, 2008

Loading next page...
 
/lp/wolters-kluwer-health/prophylactic-antiretroviral-regimens-for-prevention-of-mother-to-child-qAROckx7SC

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0b013e3282f51b89
pmid
19372960
Publisher site
See Article on Publisher Site

Abstract

Prophylactic antiretroviral regimens for prevention of mother-to- child transmission of HIV in resource-limited settings Elise Arrive´ and Franc ¸ois Dabis INSERM 593, Institute for Public Health, Epidemiology Purpose of review and Development (ISPED), Victor Segalen University, With the large international mobilization against HIV/AIDS, more HIV-infected people in Bordeaux, France resource-limited settings have access to antiretroviral therapy, including pregnant Correspondence to Dr Elise Arrive´, Unite´ INSERM 593, women. The relevance of simplified prophylactic antiretroviral regimens for the Institut de Sante´ Publique, Epide´miologie et De´veloppement (ISPED), Universite´ Victor Segalen prevention of mother-to-child transmission of HIV may become questionable due to their Bordeaux 2, 146, rue Le´o Saignat, 33076 lower efficacy and their higher risk of inducing viral resistance than fully suppressive BORDEAUX Cedex, France Tel: +33 5 5757 4810; fax: +33 5 5757 4528; antiretroviral therapy. e-mail: Elise.arrive@isped.u-bordeaux2.fr Recent findings Field implementation of current recommendations, impact of prophylactic regimens on Current Opinion in HIV and AIDS 2008, 3:161– subsequent antiretroviral therapy response and possible new indications of antiretroviral therapy in pregnant women will be reviewed in this paper. Summary Prophylactic antiretroviral prevention of mother-to-child transmission regimens reached only 10% of the HIV-infected pregnant women in 2006, who were usually offered single-

Journal

Current Opinion in HIV and AidsWolters Kluwer Health

Published: Mar 1, 2008

There are no references for this article.